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Abstract
Background: Transient ischemic attack (TIA) patients are at a high vascular risk. Recently the ABCD2 score was 
validated for evaluating short-term stroke risk after TIA. We assessed the value of this score to predict the vascular 
outcome after TIA during medium- to long-term follow-up.
Methods: The ABCD2 score of 176 TIA patients consecutively admitted to the Stroke Unit was retrospectively 
calculated and stratified into three categories. TIA was defined as an acute transient focal neurological deficit caused by 
vascular disease and being completely reversible within 24 hours. All patients had to undergo cerebral MRI within 5 
days after onset of symptoms as well as extracranial and transcranial Doppler and duplex ultrasonography. At a median 
follow-up of 27 months, new vascular events were recorded. Multivariate Cox regression adjusted for EDC findings and 
heart failure was performed for the combined endpoint of cerebral ischemic events, cardiac ischemic events and death 
of vascular or unknown cause.
Results: Fifty-five patients (32.0%) had an ABCD2 score ≤ 3, 80 patients (46.5%) had an ABCD2 score of 4-5 points and 
37 patients (21.5%) had an ABCD2 score of 6-7 points. Follow-up data were available in 173 (98.3%) patients. Twenty-
two patients (13.8%) experienced an ischemic stroke or TIA; 5 (3.0%) a myocardial infarction or acute coronary 
syndrome; 10 (5.7%) died of vascular or unknown cause; and 5 (3.0%) patients underwent arterial revascularization. An 
ABCD2 score > 3 was significantly associated with the combined endpoint of cerebral or cardiovascular ischemic 
events, and death of vascular or unknown cause (hazard ratio (HR) 4.01, 95% confidence interval (CI) 1.21 to 13.27). 
After adjustment for extracranial ultrasonographic findings and heart failure, there was still a strong trend (HR 3.13, 95% 
CI 0.94 to 10.49). Whereas new cardiovascular ischemic events occurred in 9 (8.3%) patients with an ABCD2 score > 3, 
this happened in none of the 53 patients with a score ≤ 3.
Conclusions: An ABCD2 score > 3 is associated with an increased general risk for vascular events in the medium- to 
long-term follow-up after TIA.
Background
After a transient ischemic attack (TIA), patients are at
high risk of further vascular events. Whereas recurrence
of cerebral ischemia dominates the short-term prognosis
after TIA, with the 90-day stroke risk ranging from 4% to
20%,[1-6] cardiovascular disease becomes the major
cause of death on long-term follow-up after TIA and
ischemic stroke[7]. This observation is consistent with a
high prevalence of asymptomatic coronary artery disease
(CAD) in patients with TIA and mild ischemic stroke,
which has been shown to vary between 28% and 41% in
several studies[8-10].
Recently a new scoring system for evaluating the short-
term stroke risk after TIA based on five clinical factors
(age, blood pressure, clinical features consisting of unilat-
eral weakness or speech impairment, duration of symp-
toms, diabetes) has been validated and termed the
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ABCD2 score[11]. Higher scores were significantly associ-
ated with an increased stroke risk at 2, 7, and 90 days, and
patients accordingly stratified as high (score 6-7), moder-
ate (score 4-5), and low risk (score 0-3). Three subsequent
studies have previously validated the predictive value of
the ABDC score in identifying TIA patients with a high
risk of early stroke and have given proof of its simple
applicability in clinical assessment[12-14].
I n  t h i s  s t u d y ,  w e  a i m e d  t o  a s s e s s  t h e  v a l u e  o f  t h e
ABCD2 score in predicting both the cerebrovascular and
cardiovascular prognosis during medium- to long-term
follow-up after TIA.
Methods
Patient selection
We identified 262 patients with possible cerebral TIA
who had been consecutively admitted to the Stroke Unit
of the Department of Neurology between May 2000 and
July 2004. For admission to the Stroke Unit patients have
to present with a sudden onset of one or more of the fol-
lowing symptoms being suspicious for a cerebrovascular
event: hemiparesis, speech disorder, hemianopsia, gait
disturbance, vertigo, dysphagia, disturbance of con-
sciousness, deviation of head and/or ocular bulbs. The
major part of patients is assigned by the headquarters of
the accident ambulance which is skilled in recognizing
symptoms of stroke. Only a small proportion of patients
is assigned by registered practitioners or seeks medical
advice of its own volition in the accident and emergency
department of our hospital. The Stroke Unit also takes
admission from nursing home facilities. Located in the
centre of a German city it serves an urban area.
Diagnosis was made by the attending neurologist
before patient selection. TIA was defined as an acute
transient focal neurological deficit caused by vascular dis-
ease, which completely reversed within 24 hours[15].
Amaurosis fugax was not considered as TIA. To be eligi-
ble, patients had to undergo cerebral magnetic resonance
imaging (MRI) including diffusion-weighted imaging
(DWI) sequences within 5 days after onset of symptoms,
which was the case in 225 patients. 49 patients were
excluded for the following reasons: competing differential
diagnosis as assessed by the attending neurologist, 41
cases (migraine, 8 cases; epilepsy, 7 cases; functional dis-
order, 5 cases; peripheral dizziness, 4 cases; syncope, 4
cases; hypertensive crisis, 4 patients; others, 9 cases);
malignancy requiring active treatment, 7 cases; concomi-
tant participation in a pharmaceutical trial, 1 case.
Informed written or oral consent was obtained from all
patients at date of follow-up. The study was approved by
the local institutional review board ("Ethikkommission
der Fakultät für Medizin der Technischen Universität
München"). All research carried out in participating sub-
jects was in compliance with the Helsinki Declaration.
Baseline clinical variables
The ABCD2 score at time of admission was retrospec-
tively calculated by evaluating medical records as follows:
age (≥60 years, 1 point); blood pressure on first assess-
ment after TIA (systolic blood pressure (SBP) ≥140
mmHg or diastolic blood pressure (DBP) ≥90 mmHg, 1
point); clinical features of TIA (unilateral weakness, 2
points; speech impairment without weakness, 1 point);
duration of symptoms (≥60 minutes, 2 points; 10-59 min-
utes, 1 point); diabetes (1 point). In accordance with
Johnston et al., the ABCD2 score was stratified into three
categories (≤ 3 points, low; 4-5 points, moderate; 6-7
points, high)[11].
In addition, the following data were collected: sex; pres-
ence of conventional vascular risk factors; and medical
history of coronary artery disease (CAD), heart failure,
and symptomatic peripheral artery disease (PAD). Hyper-
tension was defined as systolic blood pressure ≥140
mmHg, diastolic blood pressure ≥90 mmHg, or current
use of antihypertensive medication; diabetes mellitus as
fasting blood glucose ≥126 mg/dL or current use of antid-
iabetic agents; hypercholesterolemia as total cholesterol
≥240 mg/dL or current use of lipid-lowering medication;
nicotine abuse as current or former regular smoking; and
atrial fibrillation as history of electrocardiographically
documented intermittent or persistent atrial fibrillation.
Diagnostic criteria for myocardial infarction (MI) were
typical rise and gradual fall (Troponin T) or more rapid
rise and fall (CK-MB) of biochemical markers of myocar-
dial necrosis with at least one of the following: ischemic
symptoms (e.g. chest pain), development of pathological
Q waves on ECG, ECG changes indicative of ischemia
(ST segment elevation or depression) or coronary artery
intervention (e.g. coronary angioplasty). Acute coronary
syndrome (ACS) was defined as acute myocardial isch-
emic state also encompassing unstable angina and non-
ST segment elevation myocardial infarction without
measurable changes of biochemical markers of myocar-
dial necrosis. For coding MI and ACS medical reports
from other hospitals or family doctors were obtained.
Ultrasonography protocol
Extracranial Doppler and duplex ultrasonography (ECD)
and transcranial Doppler and duplex ultrasonography
(TCD) were performed using multi-range Doppler (DWL
Multi-Dop; Compumedics Germany GmbH) and duplex
ultrasound devices (Siemens Sonoline Elegra; Siemens
AG).
ECD findings were classified as stenotic or occlusive if
ECD showed at least one stenosis ≥50% or an occlusion of
the cervical internal carotid (cICA) or vertebrobasilar
(VBA) arteries. TCD findings were classified as abnormal
if TCD revealed at least one intracranial stenosis or an
occlusion of the distal internal carotid (dICA), middleHolzer et al. BMC Neurology 2010, 10:50
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cerebral (MCA), or posterior cerebral (PCA) arteries, or
detected collateral blood flow through the circle of Willis
secondary to extracranial lesions. TCD diagnosis of
intracranial stenosis was defined by increased peak flow
velocities (≥155 cm/s for dICA and MCA; ≥100 cm/s for
PCA) with side-to-side differences > 20% and disturbed
flow patterns[16].
MRI protocol
Cerebral MRI was performed within a maximum of 5
days after onset of symptoms in all patients. All MRI
scans were obtained using a 1.5-Tesla scanner (Magne-
tom Symphony; Siemens AG). The imaging protocol
included axial T1-weighted, T2-weighted and DWI
sequences and in doubtful cases additionally a sagittal or
coronal DWI sequence. Apparent diffusion coefficient
(ADC) maps were constructed by linear least-squares fit
on a pixel-by-pixel basis after averaging the direction-
dependent DWI values. DWI scans were considered pos-
itive for ischemia if both a hyperintensity on the isotropic
b = 1000 scan and a corresponding hypointensity on the
ADC map were detectable.
Clinical endpoints
At a median follow-up of 27 months (minimum 4
months, maximum 64 months, interquartile range [IQR]
18-41 months), all 176 patients were contacted by tele-
phone or mail for evaluation of new vascular events. The
data set was completed by information obtained from rel-
atives, attending physicians and/or hospitals. Our main
points of interest were cerebral ischemic events (ischemic
stroke or TIA), cardiovascular ischemic events (myocar-
dial infarction (MI) or acute coronary syndrome (ACS),
surgical or endovascular revascularization procedures in
CAD or PAD), and death of vascular or unknown cause.
Other vascular events and death of nonvascular cause
also were documented. The interviewer was blinded to
the ABCD2 score.
Statistical analysis
All analyses were performed using the SPSS statistical
package version 15.0. For statistical analysis, the ABCD2
score was trichotomized into three categories (≤ 3 points,
low; 4-5 points, moderate; 6-7 points, high). For interpre-
tation and summary of results, the ABCD2 score was
dichotomized into low values (≤ 3 points) versus moder-
ate or high values (> 3 points), as the proportion of
patients with high ABCD2 scores of 6 or more points was
relatively small. Association of risk factors was assessed
by Student t test for normally distributed data and χ2 test
for categorized variables. Univariate Cox proportional
hazards regression model was used to identify variables
a s s o c i a t e d  w i t h  t h e  o c c u r r e n c e  o f  e n d p o i n t s .  F o r  t h e
combined endpoint of cerebral ischemic events, cardiac
ischemic events, and death of vascular or unknown cause,
multivariate Cox regression analysis adjusted for ECD
findings and heart failure at baseline was performed in
addition. As ECD findings were strongly correlated with
TCD results and PAD at baseline, no further variables
were added to the multivariate analysis. Associations are
presented as hazard ratios (HR) with corresponding 95%
confidence intervals (CI); P < 0.05 was considered as sig-
nificant. Percentage values are relative to the patient sub-
set with complete data record.
Results
A total of 176 Caucasian TIA patients were included in
the study. Baseline characteristics of the study population
are given in Tables 1 and 2. Notably, patients with a mod-
erate or high ABCD2 score were significantly more likely
to show DWI signal intensity changes suggestive of cere-
bral ischemia than patients with a low ABCD2 score.
Medical history revealed former ischemic stroke, TIA, or
amaurosis fugax in 40 (23.1%) patients. Nine (5.1%)
patients experienced a TIA in the month before admis-
sion. Distribution of ABCD2 categories was as follows: 0-
3 points, 55 (32.0%) patients; 4-5 points, 80 (46.5%)
patients; 6-7 points, 37 (21.5%) patients. In 4 patients the
ABCD2  score could not be assigned to any category
because of missing data on blood pressure and/or diabe-
tes.
DWI showed signal intensity changes suggestive of
cerebral ischemia in 49 (28.3%) patients. ECD detected
stenoses ≥50% or occlusions of the cICA or VBA in 34
(19.3%) patients. Six (3.4%) patients had a high-grade
cICA stenosis as defined by a local degree of stenosis
≥80%. Five of these six patients subsequently underwent
carotid endarterectomy and 1 underwent stent-sup-
ported angioplasty. TCD revealed intracranial stenoses in
14 (8.6%) patients and reactive collateral blood flow due
to cICA stenosis in 6 (3.7%) patients. In 13 (7.4%)
Table 1: Single Items of ABCD2 Score in study population 
(n = 172)
Age (years)* 63.3 ± 14.9
≥60 years 113 (62.2%)
SBP ≥140 mmHg/
DBP ≥90 mmHg
95 (54.0%)
Clinical features
Unilateral weakness 34 (19.3%)
Speech impairment only 97 (55.1%)
Duration of symptoms
10-59 minutes 36 (20.5%)
≥60 minutes 108 (61.4%)
Diabetes (n) 30 (17.0%)Holzer et al. BMC Neurology 2010, 10:50
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patients, TCD could not be applied because of inadequate
temporal bone windows.
Follow-up data were available for 173 (98.3%) patients.
In 9 (5.7%) patients an ischemic stroke and in 14 (8.8%) a
new TIA was diagnosed. 9 (5.7%) more patients reported
symptoms consistent with cerebral ischemia but did not
seek medical aid or had competing differential diagnoses
as reported by attending physicians and/or hospitals. No
patient experienced a new cerebral ischemic event before
study MRI. Three (1.8%) patients were diagnosed with
acute MI and 2 (1.2%) with ACS; a further 4 (2.4%)
patients underwent surgical or endovascular revascular-
ization in CAD, and 1 (0.6%) patient had bypass surgery
in PAD. Additionally, four (2.4%) patients suffered from
their first-ever angina pectoris attack, and 10 (6.0%)
patients experienced other non-ischemic vascular events
(cardiac syncope, 4 cases; pacemaker implantation, 2
cases; aortic valve surgery, 1 case; Wolff-Parkinson-
White syndrome, 1 case; deep vein thrombosis, 1 case;
pulmonary embolism, 1 case). At the time of follow-up,
15 (8.5%) patients had died for the following reasons: car-
diac failure, 3 (1.7%); malignancy, 3 (1.7%); pneumonia, 2
(1.1%); unknown cause, 7 (4.0%). No cardiovascular isch-
emic event happened within the first 90 days after index
TIA.
Results of univariate Cox regression analysis are shown
in Table 3. Notably, moderate or high ABCD2 scores were
significantly associated with the combined endpoint of
cerebral ischemic events, cardiac ischemic events, and
death of vascular or unknown cause (hazard ratio (HR)
4.01, 95% confidence interval (CI) 1.21 to 13.27, P = 0.02).
After adjustment for ECD findings and heart failure there
remained a strong trend, but this did not reach signifi-
cance (HR 3.13, 95% CI 0.94 to 10.49, P = 0.06). Of the
single ABCD2  factors, only the presence of unilateral
weakness was significantly associated with the combined
endpoint in univariate analysis (HR 3.37, 95% CI 1.00 to
11.30, P = 0.049), but there was also a trend for patients
aged ≥60 years (HR 2.15, 95% CI 0.88 to 5.26, P = 0.09).
As no cardiovascular ischemic events happened in
patients with an ABCD2 score ≤ 3 or an initial blood pres-
sure < 140/90 mmHg, the association between moderate
or high ABCD2 scores or hypertensive blood pressure val-
ues and the occurrence of cardiovascular ischemic events
could not be assessed by statistical analysis. Of the other
single ABCD2  factors, only diabetes was significantly
associated with new cardiovascular ischemic events in
univariate analysis (HR 4.94, 95% CI 1.41 to 17.30, P =
0.01). We also observed a trend in patients aged ≥60 years
(HR 5.30, 95% CI 0.67 to 41.89, P = 0.11) and for patients
who developed speech impairment without weakness
(HR 8.68, 95% CI 0.96 to 78.42, P = 0.05).
The presence of moderate or high ABCD2 scores (HR
2.73, 95% CI 0.81 to 9.29, P = 0.11) or unilateral weakness
(HR 4.14, 95% CI 0.96 to 17.92, P = 0.06) tended to be
associated with further cerebrovascular ischemic events
in univariate analysis, but significance was not reached in
either case. There were also no significant associations
between any of the other single ABCD2 factors and the
occurrence of cerebrovascular ischemic events. Table 4
shows the graded risk of new vascular events related to
person-years based on the trichotomized ABCD2 score,
Table 2: Patient characteristics of study population
ABCD2 ≤ 3
n = 55
3 > ABCD2 < 6
n = 80
ABCD2 ≥6
n = 37
Sex, female n (%) 26 (47,3) 26 (32,5) 14 (37,8)
Hypertension n (%) 34 (61,8) 57 (71,3) 32 (86,5)
Hypercholesterolemia n (%) 24 (43,6) 40 (50,0) 18 (48,6)
Body mass index mean ± SD 25,8 ± 3,9 25,8 ± 3,8 26,0 ± 4,0
Nicotine abuse n (%) 22(40,0) 41(51,3) 15(40,5)
Atrial fibrillation n (%) 4(7,3) 12(15,0) 7(18,9)
Coronary artery disease n (%) 9(16,4) 16(20,0) 10(27,0)
Heart failure n (%) 4(7,3) 4(5,0) 3(8,1)
Peripheral artery disease n (%) 3(5,5) 7(8,8) 3(8,1)
DWI abnormality n (%) 9(16,4) 23(28,8) 16(43,2)
ECD: stenotic/occlusive n (%) 8(14,5) 15(18,8) 10(27,0)
TCD: abnormal n (%) 4(7,3) 11(13,8) 5(13,5)
*Mean ± standard deviation.
SBP: systolic blood pressure. DBP: diastolic blood pressure. ECD: extracranial Doppler and duplex ultrasonography. TCD: transcranial Doppler 
and duplex ultrasonography.Holzer et al. BMC Neurology 2010, 10:50
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Table 3: Cox regression analysis of individual risk factors for new vascular events
Cerebral ischemic 
event
Cardiovascular ischemic 
event
Cerebral/cardiac ischemic 
events, or death of vascular/
unknown cause
HR 95% CI HR 95% CI HR 95% CI
3 < ABCD2 > 6 2.71 0.76-9.60 -* -* 3.91 1.14-13.34
ABCD2 ≥6 2,61 0.62-10.93 -* -* 4.26 1.13-16.08
Age ≥60 years 1.30 0.50-3.35 5.30 0.67-41.89 2.15 0.88-5.26
SBP ≥140 mmHg/DBP ≥90 mmHg 0.88 0.35-2.18 -* -* 1.28 0.57-2.84
Unilateral weakness 4.14 0.96-17.92 1.80 0.20-16.10 3.37 1.00-11.30
Speech impairment only 1.39 0.20-9.90 8.68 0.96-78.42 2.62 0.66-10.47
Duration 10-59 min 1.32 0.37-4.70 1.83 0.30-10.97 1.63 0.53-4.99
Duration ≥60 min 0.80 0.25-2.50 0.64 0.12-3.48 1.00 0.37-2.72
Diabetes 1.46 0.49-4.33 4.94 1.41-17.30 1.83 0,79-4.26
Sex, female 1.13 0.49-2.62 0.93 0.23-3.76 1.18 0.56-2.45
Hypertension 0.99 0.39-2.51 -** -** 1.20 0.54-2.68
Hypercholesterolemia 0.57 0.24-1.34 2.51 0.65-9.70 0.51 0.24-1.10
Body mass index 0.30 0.04-2.24 1.06 0.21-5.26 0.52 0.15-1.76
Nicotine abuse 1.30 0.57-2.94 0.99 0.27-3.69 1.06 0.53-2.12
Atrial fibrillation 0.94 0.28-3.17 -** -** 1.02 0.35-2.93
Coronary artery disease 0.59 0.18-1.99 2.27 0.62-8.24 0.96 0.41-2.24
Heart failure 3.39 1.00-11.55 2.77 0.34-22.63 3.97 1.51-10.45
Peripheral artery disease 7.64 2.96-19.71 -** -** 7.42 3.25-16.94
DWI abnormality 1.23 0.51-2.93 0.59 0.12-2.85 0.84 0.37-1.90
ECD: stenotic/occlusive 4.39 1.93-9.99 3.73 1.05-13.31 4.18 2.04-8.59
TCD: abnormal 4.99 1.97-12.62 9.62 2.46-37.68 5.13 2.26-11.67
* Statistical analysis not possible owing to absence of events in one group.
** Statistical analysis not possible owing to small patient numbers.
SBP: systolic blood pressure. DBP: diastolic blood pressure. ECD: extracranial Doppler and duplex ultrasonography. TCD: transcranial Doppler 
and duplex ultrasonography.
with higher rates of both cerebral and cardiovascular
ischemic events in patients with moderate and high
ABCD2 scores.
Discussion
The results of the present study indicate that the ABCD2
score not only predicts short-term stroke risk after
TIA[11,17-19] but may also predict the general vascular
risk and particularly cardiovascular risk during medium-
to long-term follow-up after TIA. To the best of our
knowledge, this is the first study evaluating the prognos-
tic value of the ABCD2 score beyond 90 days follow-up
after TIA. However, further studies with larger patient
cohorts are necessary to confirm this association.
In addition, the present study implies a particularly
increased cardiovascular risk in TIA patients with mod-
erate or high ABCD2 scores. Although Cox regression
analysis was not possible because of the absence of events
in the patient group with low ABCD2 scores, the study
data suggest an association between moderate or high
ABCD2 scores and the occurrence of new cardiovascular
ischemic events on medium- to long-term follow-up after
TIA. This is of special importance as cardiovascular dis-
ease becomes the major cause of death on long-term fol-
low-up after TIA,[7] and asymptomatic CAD is known to
be prevalent in as many as 28-41% of patients with cere-
brovascular disease[8-10]. Healthcare professionals are
currently encouraged to optimize coronary risk evalua-
tion in patients with TIA and ischemic stroke based on
the Framingham Score and the prevalence of carotid
artery disease[20]. In clinical practice, however, coronary
risk in TIA patients often is not assessed owing to limitedHolzer et al. BMC Neurology 2010, 10:50
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time resources. As the ABCD2 score can easily be derived
within seconds, and is often calculated in acute TIA
patients anyway, further studies with larger patient
cohorts should be conducted to assess its value in pre-
dicting cardiovascular events after TIA.
Regarding cerebral ischemic events, we found only a
non-significant trend toward higher risk in patients with
moderate or high ABCD2 scores (HR 2.73, 95% CI 0.81 to
9.29,  P  = 0.11). However, the incidence of subsequent
stroke observed in this study (5.7% at a median follow-up
of 27 months) was substantially lower than in other
recent reports (7-21% at 12 months)[3,6,21,22]. Given
that the first 48 hours after TIA are the period of highest
stroke risk,[6,11,23] and urgent TIA treatment is associ-
ated with an 80% to 90% reduction in early stroke inci-
dence,[24,25] the reduced stroke incidence in our study
might be attributed to the optimized TIA patient man-
agement in our setting. All recruited patients were admit-
ted to the Stroke Unit and systematically underwent
emergency diagnostic procedures and received secondary
prevention therapies. This medical approach is routine
practice in our academic center, but differs from standard
TIA patient care in hospitals without Stroke Units.
The detected association between higher ABCD2-
scores and increasing risk of cerebral ischemic events
could be attributable to the fact that some aspects of the
ABCD score (e.g. unilateral weakness, speech impair-
ment and TIA with prolonged duration) improve the
diagnosis of TIA from non-TIA disorders (e.g. syncope or
migraine). The remaining features are important vascular
risk factors (increasing age, elevated blood pressure and
Diabetes) and are therefore likely to be relevant for the
cause of future stroke.
I n t e r e s t i n g l y ,  T I A  p a t i e n t s  w i t h  m o d e r a t e  o r  h i g h
ABCD2 scores showed an acute ischemic lesion on DWI
significantly more often than those with low ABCD2
scores (33.9% vs. 16.7%, P = 0.02). Despite emerging evi-
dence of an increased short-term stroke risk in DWI-pos-
itive TIA patients,[1,17] we found no association between
the detection of an acute ischemic lesion on DWI and the
occurrence of cerebral ischemic events during medium-
to long-term follow-up. In analogy to the above discus-
sion, both the longer follow-up interval and the high-
standard routine management of TIA patients may have
weakened the prognostic value of DWI in this study.
There was no increase in the frequency of extracranial
stenotic or occlusive disease as assessed by ECD and only
a non-significant trend for a higher incidence of abnor-
mal TCD findings in patients with an ABCD2 score > 3.
Concordantly, Koton et al. also found no relationship
between the ABCD2 score and the prevalence of a carotid
stenosis ≥50% in TIA patients[18].
The present study has several limitations. First, a larger
patient cohort would have been necessary to improve the
statistical power of the study. Moreover, the ABCD2 score
was calculated retrospectively on the basis of medical
records only and follow-up was conducted as telephone
or mail interview only. Concerning the detected associa-
tion between moderate or high ABCD2 score and higher
frequency of DWI signal intensity changes and between
moderate or high ABCD2 score and hypertension it has to
be acknowledged that these two variables are not inde-
pendent of ABDC2.
Conclusions
I n  c o n c l u s i o n ,  p a t i e n t s  w i t h  m o d e r a t e  o r  h i g h  A BCD 2
scores are at increased risk of suffering from further vas-
cular events in the medium- to long-term follow-up after
TIA. This study additionally implies a particularly
increased cardiovascular risk in these patients.
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